share_log

Viavi Solutions Analyst Ratings

Benzinga ·  Nov 3, 2023 09:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/03/2023 18.73% Morgan Stanley $10 → $9 Maintains Equal-Weight
08/31/2023 84.7% Rosenblatt → $14 Reiterates Buy → Buy
08/11/2023 84.7% Rosenblatt $13 → $14 Maintains Buy
06/09/2023 71.5% Rosenblatt → $13 Reiterates Buy → Buy
05/03/2023 31.93% Morgan Stanley $10.5 → $10 Maintains Equal-Weight
05/03/2023 58.31% Susquehanna $14 → $12 Maintains Positive
05/03/2023 71.5% Rosenblatt → $13 Reiterates → Buy
04/18/2023 45.12% B. Riley Securities $13.5 → $11 Maintains Neutral
04/18/2023 84.7% Susquehanna $16 → $14 Maintains Positive
04/18/2023 38.52% Morgan Stanley $13 → $10.5 Maintains Equal-Weight
04/18/2023 71.5% Rosenblatt $16 → $13 Maintains Buy
02/03/2023 78.1% B. Riley Securities $14.5 → $13.5 Maintains Neutral
12/20/2022 45.12% JP Morgan $13 → $11 Maintains Neutral
12/02/2022 58.31% Stifel → $12 Initiates Coverage On → Hold
11/07/2022 71.5% Morgan Stanley $16 → $13 Maintains Equal-Weight
11/04/2022 91.29% B. Riley Securities $21 → $14.5 Downgrades Buy → Neutral
10/11/2022 111.08% Morgan Stanley $17 → $16 Maintains Equal-Weight
10/06/2022 137.47% Rosenblatt → $18 Initiates Coverage On → Buy
09/14/2022 124.27% Morgan Stanley $16 → $17 Maintains Equal-Weight
08/12/2022 137.47% Susquehanna $20 → $18 Maintains Positive
07/19/2022 Needham Downgrades Buy → Hold
07/14/2022 97.89% JP Morgan $18 → $15 Maintains Neutral
05/04/2022 111.08% Morgan Stanley $17 → $16 Maintains Equal-Weight
08/13/2021 150.66% Morgan Stanley $18 → $19 Maintains Equal-Weight
07/20/2021 150.66% JP Morgan → $19 Downgrades Overweight → Neutral
07/06/2021 137.47% Morgan Stanley $16 → $18 Maintains Equal-Weight
05/05/2021 203.43% Northland Capital Markets $22 → $23 Maintains Outperform
02/03/2021 111.08% Morgan Stanley $15 → $16 Maintains Equal-Weight
02/03/2021 150.66% Needham $18 → $19 Maintains Buy
01/12/2021 137.47% Needham $16 → $18 Maintains Buy
12/15/2020 97.89% Morgan Stanley $14 → $15 Maintains Equal-Weight
08/12/2020 84.7% Morgan Stanley $13 → $14 Maintains Equal-Weight
06/19/2020 111.08% Needham $13 → $16 Maintains Buy
06/01/2020 111.08% JP Morgan $14 → $16 Upgrades Neutral → Overweight
05/07/2020 111.08% B. Riley Securities $16.5 → $16 Maintains Buy
05/07/2020 111.08% MKM Partners $17 → $16 Maintains Buy
04/13/2020 117.68% B. Riley Securities $17 → $16.5 Maintains Buy
03/19/2020 71.5% Morgan Stanley $16 → $13 Maintains Equal-Weight
03/18/2020 71.5% Needham $17 → $13 Maintains Buy
10/18/2019 150.66% Susquehanna → $19 Initiates Coverage On → Positive
04/22/2019 71.5% JP Morgan $12 → $13 Upgrades Underweight → Neutral

What is the target price for Viavi Solutions (VIAV)?

The latest price target for Viavi Solutions (NASDAQ: VIAV) was reported by Morgan Stanley on November 3, 2023. The analyst firm set a price target for $9.00 expecting VIAV to rise to within 12 months (a possible 18.73% upside). 16 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Viavi Solutions (VIAV)?

The latest analyst rating for Viavi Solutions (NASDAQ: VIAV) was provided by Morgan Stanley, and Viavi Solutions maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for Viavi Solutions (VIAV)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viavi Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viavi Solutions was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.

Is the Analyst Rating Viavi Solutions (VIAV) correct?

While ratings are subjective and will change, the latest Viavi Solutions (VIAV) rating was a maintained with a price target of $10.00 to $9.00. The current price Viavi Solutions (VIAV) is trading at is $7.58, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment